David Hassin

Medicine & Life Sciences

1. Action Potentials 32%
2. Acute Liver Failure 25%
3. Agranulocytosis 28%
4. Anti-Bacterial Agents 57%
5. Avena 31%
6. Bacterial Endocarditis 30%
7. Carcinogens 31%
8. Cardiac Myocytes 50%
9. Catheter-Related Infections 27%
10. Ceftriaxone 25%
11. Chronic Hepatitis 23%
12. Community Hospital 24%
13. Community-Acquired Infections 28%
14. Conjunctivitis 26%
15. Cryptococcus neoformans 27%
16. Cytotoxic T-Lymphocytes 100%
17. Empyema 27%
18. Epidural Abscess 31%
19. Erythema Infectiosum 31%
20. Familial Mediterranean Fever 29%
21. Fas Ligand Protein 37%
22. Gene Amplification 25%
23. HIV 60%
24. Human Enterovirus D 35%
25. Hyperemesis Gravidarum 33%
26. Indwelling Catheters 26%
27. Infections 35%
28. Israel 87%
29. Listeria monocytogenes 25%
30. Listeriosis 29%
31. Liver 29%
32. Lymphocytes 30%
33. Mengovirus 67%
34. Muscle Cells 52%
35. Neurologic Manifestations 22%
36. nimesulide 31%
37. nitinol 27%
38. Osteomyelitis 23%
39. Pasteurella multocida 31%
40. Perforin 61%
41. Persistent Vegetative State 29%
42. Pharmacy 22%
43. Propylthiouracil 29%
44. Quinidine 28%
45. Simian virus 40 54%
46. Spontaneous Remission 29%
47. Streptococcus sanguis 32%
48. T-Lymphocytes 40%
49. Virus Diseases 34%
50. Wernicke Encephalopathy 32%